Riskpilot← Back to searchSign inGet full accessCONTISCIENCE ApS
APSActiveCVR 27772323Frederiksberg Alle 32, 2. thManufacture of medical and dental instruments and supplies · NACE 3250Est. 2004— employees
Revenue 2025
DKK -6K
+13% vs 2024
EBITDA margin
100.0%
-13% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
DKK 8K
+1% vs 2024
| Revenue | DKK -6K | +13% |
| EBITDA | DKK -6K | -13% |
| Net profit | DKK 8K | +1% |
| Total assets | DKK 250K | +6% |
| Equity | DKK 225K | +4% |
| Employees | — | — |
Legal name
CONTISCIENCE ApS
CVR number
27772323
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1. juni 2004
Share capital
DKK 200.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed indenfor forskning, produktion og salg af medicoudstyr.
Address
Frederiksberg Alle 32, 2. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 142 | -0 | -0 | -1 | 187 | -1 | -0 | -0 | -0 | -0 | -10 | -6 | -5 | -6 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 142 | -0 | -0 | -1 | 187 | -1 | -0 | -0 | -0 | -0 | -10 | -6 | -5 | -6 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 142 | -0 | -0 | -1 | 187 | -1 | -0 | -0 | -0 | -0 | -10 | -6 | -5 | -6 |
| Net financials | 3 | 6 | 6 | 8 | 15 | 17 | 13 | 12 | 12 | 12 | 12 | 13 | 13 | 14 |
| Profit before tax | 146 | 6 | 6 | 7 | 203 | 16 | 13 | 12 | 12 | 12 | 2 | 7 | 8 | 8 |
| Tax | 6 | 1 | 1 | 0 | 36 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 140 | 4 | 4 | 7 | 167 | 15 | 13 | 12 | 12 | 12 | 2 | 7 | 8 | 8 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 180 | 159 | 164 | 169 | 419 | 216 | 213 | 212 | 212 | 212 | 212 | 224 | 237 | 250 |
| Equity | 154 | 158 | 162 | 169 | 200 | 215 | 213 | 212 | 212 | 212 | 202 | 209 | 217 | 225 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26 | 1 | 1 | 0 | 219 | 0 | 0 | 0 | 0 | 0 | 10 | 15 | 20 | 25 |
| Total debt | 26 | 1 | 1 | 0 | 219 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 20 | 25 |
EBITDA margin
-575000.0%
This company
15.8%
Market median
-3639341% vs market
20122025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20122025
Return on equity
3.7%
This company
18.4%
Market median
-80% vs market
20122025
Net profit margin
841500.0%
This company
8.1%
Market median
+10388789% vs market
20122025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
GO Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MULTICEPT ApS | Company | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CIGNET ApS
CONTISCIENCE ApS Board members of CONTISCIENCE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andre Michael Kowalczyk | Chief Executive Officer | 0 companies |
| Gitte Olsen Kowalczyk | Chief Executive Officer | 0 companies |
| Dorte Saabye | Board of Directors | 0 companies |
| Jens Otto Reimers Sønksen | Chairman | 0 companies |
| Michael Vang-Pedersen | Chairman | 0 companies |